Skip to Main Content

Advertisement

American Association for Cancer Research Logo Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 2, Issue 6
1 June 2003
Molecular Cancer Therapeutics Cover Image for Volume 2, Issue 6
All Issues
ISSN 1535-7163
EISSN 1538-8514
Issue Sections

ARTICLE

Reduction of β-Catenin/T-Cell Transcription Factor Signaling by Aspirin and Indomethacin Is Caused by an Increased Stabilization of Phosphorylated β-Catenin
Susanne Dihlmann; Simone Klein; Magnus von Knebel Doeberitz
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Characterization of the Cytotoxic Activities of Novel Analogues of the Antitumor Agent, Lavendamycin1
Yanan Fang; Corinne M. Linardic; D. Ashley Richardson; Wen Cai; Mohammad Behforouz; Robert T. Abraham
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Cytochrome P450 1B1 (CYP1B1) Is Overexpressed in Human Colon Adenocarcinomas Relative to Normal Colon: Implications for Drug Development1
Paul Gibson; Jason H. Gill; Parveen A. Khan; Jill M. Seargent; Sandie W. Martin; Philip A. Batman; John Griffith; Christopher Bradley; John A. Double; Michael C. Bibby; Paul M. Loadman
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
mRNA Expression Levels of E2F Transcription Factors Correlate with Dihydrofolate Reductase, Reduced Folate Carrier, and Thymidylate Synthase mRNA Expression in Osteosarcoma1
Rebecca Sowers; Junya Toguchida; Jing Qin; Paul A. Meyers; John H. Healey; Andrew Huvos; Debabrata Banerjee; Joseph R. Bertino; Richard Gorlick
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Human Chk1 Expression Is Dispensable for Somatic Cell Death and Critical for Sustaining G2 DNA Damage Checkpoint
Zehan Chen; Zhan Xiao; Jun Chen; Shi-Chung Ng; Thomas Sowin; Hing Sham; Saul Rosenberg; Steve Fesik; Haiying Zhang
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Flavopiridol Enhances the Effect of Docetaxel in Vitro and in Vivo in Human Gastric Cancer Cells1
Monica Motwani; Carina Rizzo; Francis Sirotnak; Yuhong She; Gary K. Schwartz
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
ZD1839, a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Shows Antimetastatic Activity Using a Hepatocellular Carcinoma Model1
Mitsuhiro Matsuo; Hiroaki Sakurai; Ikuo Saiki
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Cytoreductive Effects of Farnesyl Transferase Inhibitors on Multiple Myeloma Tumor Cells1
Yijiang Shi; Joseph Gera; Jung-hsin Hsu; Brian Van Ness; Alan Lichtenstein
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Minireview

Why Target Apoptosis in Cancer Treatment?
Shailaja Kasibhatla; Ben Tseng
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Evaluation of Cancer Therapy Using Diffusion Magnetic Resonance Imaging1
Brian D. Ross; Bradford A. Moffat; Theodore S. Lawrence; Suresh K. Mukherji; Stephen S. Gebarski; Douglas J. Quint; Timothy D. Johnson; Larry Junck; Patricia L. Robertson; Karin M. Muraszko; Qian Dong; Charles R. Meyer; Peyton H. Bland; Patrick McConville; Hairong Geng; Alnawaz Rehemtulla; Thomas L. Chenevert
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Targeting Aurora-2 Kinase in Cancer1
Steven L. Warner; David J. Bearss; Haiyong Han; Daniel D. Von Hoff
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Advertisement

Latest News
Expanding the Targeted Protein Degradation Arsenal
AI Model Could Make Cachexia Detection Easier
Drugging WRN: Clinical Proof-of-Concept Established
View more recent articles
Breaking
Retifanlimab Approved for Anal Cancer
ADC for Lung Cancer Approved
First Oral Treatment for Adrenal Tumors OK’d
View more recent articles
Research Watch
A Single-Cell Atlas Reveals Characteristics of Pan-Cancer Brain Metastases
BRCA2 Mitigates PARP1 Retention at DNA Repair Sites to Stabilize RAD51
ROS Sensing Regulates Mitochondrial Translation and Chemotherapy Response
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck.  None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1538-8514
  • Print ISSN 1535-7163

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept